Peanut Allergy Treatment From Aimmune Gets FDA Panel Nod – Investor's Business Daily

Peanut Allergy Treatment From Aimmune Gets FDA Panel Nod – Investor's Business Daily

Peanut Allergy Treatment From Aimmune Gets FDA Panel Nod  Investor’s Business DailyA Food and Drug Administration panel determined Friday the benefits of Aimmune Therapeutics’ peanut allergy treatment outweigh the risks.

* continue to the original Peanut Allergy Treatment From Aimmune Gets FDA Panel Nod – Investor's Business Daily

Share